9GKE
 
 | | ERAP1 in complex with 1-[2-(2-oxo-5-phenyl-2,3-dihydro-1,3-benzothiazol-3-yl)acetamido]cyclohexane-1-carboxylic acid | | Descriptor: | 1,2-ETHANEDIOL, 1-[2-(2-oxidanylidene-5-phenyl-1,3-benzothiazol-3-yl)ethanoylamino]cyclohexane-1-carboxylic acid, Endoplasmic reticulum aminopeptidase 1, ... | | Authors: | Chung, C. | | Deposit date: | 2024-08-23 | | Release date: | 2025-01-22 | | Method: | X-RAY DIFFRACTION (1.367 Å) | | Cite: | Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug Design.
Acs Med.Chem.Lett., 15, 2024
|
|
9GJS
 | | ERAP1 in complex with 1-[2-(6-bromo-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl)acetamido]-4,4-difluorocyclohexane-1-carboxylic acid | | Descriptor: | 1,2-ETHANEDIOL, 1-[2-(6-bromanyl-3-oxidanylidene-1,4-benzoxazin-4-yl)ethanoylamino]-4,4-bis(fluoranyl)cyclohexane-1-carboxylic acid, Endoplasmic reticulum aminopeptidase 1, ... | | Authors: | Rowland, P. | | Deposit date: | 2024-08-22 | | Release date: | 2025-01-22 | | Method: | X-RAY DIFFRACTION (1.351 Å) | | Cite: | Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug Design.
Acs Med.Chem.Lett., 15, 2024
|
|
9GK6
 | | ERAP1 in complex with 1-[2-(6-chloro-3-oxo-3,4-dihydro-2H-1,4-benzothiazin-4-yl)acetamido]cyclohexane-1-carboxylic acid | | Descriptor: | 1,2-ETHANEDIOL, 1-[2-(6-chloranyl-3-oxidanylidene-1,4-benzothiazin-4-yl)ethanoylamino]cyclohexane-1-carboxylic acid, D-MALATE, ... | | Authors: | Convery, M, Rowland, P. | | Deposit date: | 2024-08-23 | | Release date: | 2025-01-22 | | Method: | X-RAY DIFFRACTION (1.327 Å) | | Cite: | Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug Design.
Acs Med.Chem.Lett., 15, 2024
|
|
9GJN
 | | ERAP1 in complex with 1-[2-(3-oxo-3,4-dihydro-2H-1,4-benzothiazin-4-yl)acetamido]cyclohexane-1-carboxylic acid | | Descriptor: | 1,2-ETHANEDIOL, 1-[2-(3-oxidanylidene-1,4-benzothiazin-4-yl)ethanoylamino]cyclohexane-1-carboxylic acid, 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, ... | | Authors: | Rowland, P. | | Deposit date: | 2024-08-22 | | Release date: | 2025-01-22 | | Method: | X-RAY DIFFRACTION (1.717 Å) | | Cite: | Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug Design.
Acs Med.Chem.Lett., 15, 2024
|
|
